Nantahala Capital Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
3,439,594
+451,611
| +15% | +$2.31M | 0.69% | 23 |
|
|
2025
Q1 | $4.09M | Buy |
2,987,983
+183,573
| +7% | +$251K | 0.16% | 69 |
|
|
2024
Q4 | $8.67M | Buy |
+2,804,410
| New | +$8.67M | 0.37% | 45 |
|
|
2022
Q2 | – | Sell |
-98,794
| Closed | -$749K | – | 120 |
|
|
2022
Q1 | $749K | Sell |
98,794
-1,206
| -1% | -$9.14K | 0.03% | 89 |
|
|
2021
Q4 | $1.09M | Hold |
100,000
| – | – | 0.04% | 95 |
|
|
2021
Q3 | $1.29M | Buy |
+100,000
| New | +$1.29M | 0.04% | 90 |
|
|
2021
Q2 | – | Sell |
-175,915
| Closed | -$1.96M | – | 119 |
|
|
2021
Q1 | $1.96M | Sell |
175,915
-24,085
| -12% | -$268K | 0.06% | 83 |
|
|
2020
Q4 | $2.29M | Hold |
200,000
| – | – | 0.07% | 88 |
|
|
2020
Q3 | $2.07M | Buy |
+200,000
| New | +$2.07M | 0.06% | 83 |
|